Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Oragenics, Inc. OGEN
$3.32
+$0.12 (3.66%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
7728139.00000000
-
week52high
24.00
-
week52low
2.60
-
Revenue
131521
-
P/E TTM
-1
-
Beta
0.35605500
-
EPS
-6.86000000
-
Last Dividend
0.00000000
-
Next Earnings Date
27 июл 2023 г. в 20:00
Описание компании
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement with Precigen, Inc. and ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Goldman Sachs | Neutral | 03 июн 2021 г. | |
| H.C. Wainwright | Neutral | Buy | 16 апр 2020 г. |
| UBS | Neutral | Neutral | 15 ноя 2019 г. |
| H.C. Wainwright | Buy | 26 апр 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| KOSKI ROBERT C | D | 1102295 | 42357 | 30 дек 2022 г. |
| KOSKI ROBERT C | D | 176191 | 36648 | 29 дек 2022 г. |
| KOSKI ROBERT C | D | 1144652 | 140497 | 15 дек 2022 г. |
| KOSKI ROBERT C | D | 1285149 | 25000 | 14 дек 2022 г. |
| KOSKI ROBERT C | D | 1310149 | 4503 | 14 дек 2022 г. |
| KOSKI ROBERT C | D | 1314652 | 48795 | 09 дек 2022 г. |
| KOSKI ROBERT C | D | 1363447 | 13036 | 08 дек 2022 г. |
| KOSKI ROBERT C | D | 1376483 | 200000 | 30 ноя 2022 г. |
| KOSKI ROBERT C | D | 1576483 | 200000 | 29 ноя 2022 г. |
| KOSKI ROBERT C | A | 220000 | 220000 | 29 июл 2022 г. |
Новостная лента
7 Short-Squeeze Stocks to Buy Before They Soar
InvestorPlace
30 янв 2023 г. в 14:24
As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries cathartic value. Fundamentally, market bears operate like great white sharks.
Trading Penny Stocks Under $1: Strategies for Succes & 7 To Watch
PennyStocks
26 дек 2022 г. в 14:20
Penny stocks to buy under $1: A Beginner's Guide The post Trading Penny Stocks Under $1: Strategies for Succes & 7 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.